MedTrace Logo

Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

NCT07012863 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2025-09-17

No results posted yet for this study

Summary

The overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock.

Researchers will compare dry plasma to standard care to see if dry plasma improves survival compared to crystalloid fluid in prehospital patients with heavy bleeding.

Conditions

  • Bleeding
  • Aortic Rupture
  • Gastrointestinal Hemorrhage
  • Obstetric Bleeding
  • Blunt Injury
  • Penetrating Injury

Interventions

BIOLOGICAL

Dry plasma

Patient that fulfil the inclusion criteria for this study and are randomized for active treatment will get dry plasma as intervention.

Sponsors & Collaborators

  • Vastra Gotaland Region

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-06-30
Completion
2027-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07012863 on ClinicalTrials.gov